BIOTECH: CANCER DRUG FAILED TO EXTEND PATIENT LIVES
After Missing Mark in Clinical Trials, Halozyme Focuses on Delivery Platform
Sunday, November 10, 2019
Phillip Britanabe, senior research associate at Halozyme, works in the company’s lab. Photo by Jamie Scott Lytle.
For many biotechs, the news would be a death knell...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know